Date: 2017-08-02
Type of information: Nomination
Compound:
Company: Biophytis (France)
Therapeutic area: Ageing diseases - Muscle disorders - Ophtalmological diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On August 2nd, 2017, Biophytis announced the appointment of Dr. Manfred Horst as Business Development Officer. Manfred Horst, Doctor of Medicine (Ludwig-Maximilians-Universität, Munich), PhD in allergology and
an MBA graduate from INSEAD, is a seasoned pharmaceutical business development executive with more than 25 years of pharmaceutical industry experience in marketing, market access and health economics, that will benefit Biophytis’ operations.
- Prior to joining Biophytis, Manfred Horst was Business Development Director Europe at Merck Sharp & Dohme from 2004 to 2016, where he has been fully involved in searching, negotiating and managing partnerships.
Financial terms:
Latest news:
Is general: Yes